Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 334Carcinoma, Non-Small-Cell Lung 262Ovarian Neoplasms 177Lung Neoplasms 129Neoplasms 92Fallopian Tube Neoplasms 77Carcinoma, Ovarian Epithelial 63Neoplasm Metastasis 59Esophageal Neoplasms 58Stomach Neoplasms 49Head and Neck Neoplasms 45Squamous Cell Carcinoma of Head and Neck 44Triple Negative Breast Neoplasms 40Endometrial Neoplasms 37Adenocarcinoma of Lung 32Urinary Bladder Neoplasms 28Esophageal Squamous Cell Carcinoma 26Unspecified Adult Solid Tumor, Protocol Specific 24Uterine Cervical Neoplasms 23Carcinoma 23Melanoma 22Breast Neoplasms, Male 22Small Cell Lung Carcinoma 20Prostatic Neoplasms 20Parkinson Disease 4, Autosomal Dominant Lewy Body 20Adenocarcinoma Of Esophagus 20Recurrence 19Brenner Tumor 18Adenocarcinoma, Bronchiolo-Alveolar 18Peritoneal Neoplasms 16

Interventions

Zoledronic Acid 4saracatinib 1radium Ra 223 dichloride 1odanacatib 1etelcalcetide hydrochloride 1cabozantinib 1Vitamin D 1Standard of Care 1Progestins 1Paclitaxel 1Hormone Replacement Therapy 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Denosumab 1Calcium 1BHQ880 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bone Diseases × Paclitaxel × Clear all
NCT02442063 2016-11-30

Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions

Bayer

Phase 1 Completed
15 enrolled

Bone Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡